LBO — THE HORSHAM CLINIC
IRR: 34.2% | MOIC: 4.35x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
34.2%
IRR
4.35x
MOIC
$13.7M
Entry EV
$37.4M
Exit EV
$7.1M
Equity Invested
Sources & Uses
S&UTotal · $13.7M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $5.3M | 38.8% | |
| Sub Debt | $1.3M | 9.7% | |
| Equity | $7.1M | 51.5% | |
| Enterprise Value | $13.3M | 97.1% | |
| Transaction Fees | $0.4M | 2.9% | |
| Total Uses | $13.7M | 100.0% |
Interpretation
INTAt 4.35x MOIC and 34.2% IRR over 5 years, this deal exceeds the typical 20% hurdle — strong candidate.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $3.6M |
| Exit Ev | $37.4M |
| Net Debt At Exit | $6.7M |
| Equity At Exit | $30.7M |
| Equity Invested | $7.1M |
| Total Value Created | $23.7M |
| Value From Growth | $23.4M |
| Value From Multiple | $0.7M |
| Value From Deleveraging | 0.0% |